SCHEMBL4155593

SCHEMBL4155593

COC(=O)c1sc(-c2ccc(Br)cc2)cc1N(C(=O)C1CCC(C)CC1)C(C)C

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.42
HTT P42858 1/20 0.42
ATM Q13315 1/20 0.42
MAPT P10636 6/20 0.40
NPC1 O15118 3/20 0.40
RAB9A P51151 2/20 0.40
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
RECQL P46063 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
CASP3 P42574 1/20 0.39
SENP8 Q96LD8 1/20 0.39
SENP7 Q9BQF6 1/20 0.39
SENP6 Q9GZR1 1/20 0.39
IKBKB O14920 1/20 0.39
SLC6A3 Q01959 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13852139 1.00 KDM4E (0.42) KDM4EHTTATMMAPTNPC1
SCHEMBL2427841 0.90 MAPT (0.44) KDM4EHTTATMMAPTNPC1
SCHEMBL4147352 0.90 MAPT (0.52) KDM4EHTTATMMAPTNPC1
SCHEMBL4147348 0.90 MAPT (0.52) KDM4EHTTATMMAPTNPC1
SCHEMBL2427840 0.90 MAPT (0.44) KDM4EHTTATMMAPTNPC1
SCHEMBL4156654 0.90 KDM4E (0.53) KDM4EHTTATMMAPTNPC1
SCHEMBL4156658 0.90 KDM4E (0.53) KDM4EHTTATMMAPTNPC1
SCHEMBL4152684 0.89 MAPT (0.51) KDM4EHTTATMMAPTNPC1
SCHEMBL4154847 0.89 KDM4E (0.41) KDM4EHTTATMMAPTNPC1
SCHEMBL4154854 0.89 KDM4E (0.41) KDM4EHTTATMMAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090136448-A1 Antiviral 2-Carboxy-Thiophene Compounds CORFIELD JOHN ANDREW 2009-05-28 US disclosed
US-20090136448-A1 Antiviral 2-Carboxy-Thiophene Compounds CORFIELD JOHN ANDREW 2009-05-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090136448-A1 Antiviral 2-Carboxy-Thiophene Compounds EIF2AK2, HAVCR2, MAVS KDM4E 794/4885HTT 3552/4885ATM 4348/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.